News
Breast cancer is becoming increasingly treatable, but in some cases the disease can resurface even decades after a patient ...
Roughly one in 14 people with lower-risk myelodysplastic syndromes (LR-MDS) have an infection in the first year after ...
Funding cuts, firings and program closures at the Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), National Institutes of Health (NIH) and U.S. Agency for ...
Halda Therapeutics, a clinical-stage biotechnology company developing a novel class of cancer therapies called RIPTACTM ...
In a small study, researchers transplanted stem cells into the brains of 12 Parkinson’s patients, stopping progression and ...
During a live event, Chris Benton, MD, discussed the focus on anemia management, reducing transfusions, and improving quality ...
Cancer drugs' sexual toxicity warrants a "call to action" among oncologists to address the problem. ( Lancet Oncology) U.S.
An AI model may help identify patients with myelofibrosis at high risk of early death after transplant, according to an ...
We recently published a list of the 11 Most Promising Penny Stocks According to Analysts. In this article, we are going to ...
TScan Therapeutics, Inc.’s TCRX share price has surged by 9.62%, which has investors questioning if this is right time to sell.
Treatment with bexmarilimab and Vidaza elicited high overall response rates in both frontline and relapsed/refractory ...
We recently published a list of the 13 Best Biotech Penny Stocks to Buy According to Hedge Funds. In this article, we are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results